Who this is for: people already on Mounjaro or Wegovy, or about to start, who want to understand dose optimisation, cost reduction strategies, and what to discuss with their prescriber. This is particularly relevant if you have a modest amount to lose (under 15kg) or are at lower BMI.
Why standard titration may be more than you need
The standard titration schedule for Mounjaro takes you from 2.5mg to 15mg over roughly five months. Wegovy goes from 0.25mg to 2.4mg over a similar period, with the option now to continue to 7.2mg. The schedule is designed to maximise weight loss outcomes in clinical trials — which were conducted primarily in people with obesity who needed to lose 20–30% of their body weight.
If you're trying to lose 10kg from a starting BMI of 28, that population isn't you. The dose you need to suppress appetite sufficiently to lose 10kg is likely meaningfully lower than the dose needed to lose 35kg.
The question isn't what dose the protocol says you should reach. It's what dose actually works for your goal — and whether you can get there for less money with fewer side effects.
There are four distinct strategies worth understanding. They're not mutually exclusive — many people combine them. And importantly, none of them involves doing anything unsafe. You're always taking the same medication, just in different amounts or at different intervals.
Strategy 1: Stay at the lowest effective dose
This is the most straightforward approach and the one most compatible with standard prescribing practice. Both Mounjaro and Wegovy's titration schedules are designed to increase every four weeks — but there's no clinical requirement to escalate. The schedule exists to find the dose that produces results; if you're already finding results at a lower dose, the rational thing is to stay there.
The 3-month check is your signal. If you've lost 5% or more of your body weight by month 3 on your current dose, the medication is working. There's no benefit to escalating just because the schedule says it's time — and meaningful downsides: higher cost, increased side effects, and dosing further beyond what your goal requires.
This is fully within licensed prescribing practice. The patient information leaflets for both Mounjaro and Wegovy explicitly allow staying at doses below the maximum if the current dose is tolerated and producing results. A good prescriber will support this conversation.
Ask explicitly at your next review: "I'm responding well at this dose. Can we stay here and reassess in another 3 months rather than increasing?" Most clinicians will agree. If yours resists without clear clinical reasoning, that's worth noting.
Strategy 2: Click dosing explained
This is where it gets more interesting — and where most provider content stops, because it's commercially inconvenient for them to explain it.
How the Mounjaro KwikPen actually works
The Mounjaro KwikPen is a pre-filled auto-injector. When you prepare the injection, the pen makes audible clicking sounds as it loads the dose mechanism. A full prescribed dose — whatever strength your pen is — is delivered with exactly 60 clicks. The medication is loaded linearly: 30 clicks delivers approximately half the dose, 20 clicks approximately one third, and so on.
By stopping the injection mid-way through, you deliver a fraction of the prescribed dose. Each pen that would otherwise last four weeks at full weekly dosing now lasts longer — a pen used at half-dose lasts approximately eight weeks instead of four.
Is it safe?
There's no established safety concern with click dosing. You're simply taking less of a medication that has a wide safety margin. The medication doesn't become unsafe at lower doses — it becomes less effective. The injection technique, injection sites, rotation practice, and storage requirements are all identical.
What you lose is efficacy proportional to the reduction. Half the dose does not mean half the appetite suppression — the relationship between dose and effect is not perfectly linear. But at lower doses you will still have real receptor activation, and for someone needing modest results, this may be entirely sufficient.
Click dosing is not endorsed by Eli Lilly and is not covered in the official instructions for use. It's a practice that has emerged organically in patient communities and is grounded in how the pen mechanism works. Discuss it with your prescriber before doing it — not for permission, but so your clinical notes reflect your actual dosing and your response is correctly interpreted.
Wegovy and click dosing
The Wegovy FlexTouch pen works differently — it's a dial-and-press mechanism rather than a click-counter system, and delivers a fixed preset dose. Partial dosing from a Wegovy pen is not practically achievable in the same way. The dose optimisation strategies for Wegovy focus more on staying at a lower titration dose and extended intervals rather than click-based partial dosing.
Strategy 3: The golden dose
April 2026 update — this strategy is being phased out. Eli Lilly is rolling out a redesigned Mounjaro KwikPen from April 2026 that contains significantly less excess medication. The redesign is intended to leave little or no residual medication after the four standard doses. The golden dose may no longer be extractable from newly manufactured pens. If you have older stock, the strategy below still applies. For new pens, check whether residual medication is present before attempting extraction.
Each Mounjaro KwikPen has historically contained more medication than the four standard doses it delivers. The excess — approximately 20% of the total pen volume — existed to ensure that dead space in the pen mechanism doesn't cause underdosing. After the four standard doses were delivered via the auto-injector, this residual medication remained in the pen.
By using an insulin syringe to extract this residual medication and inject it separately, it was possible to get a fifth injection from a four-dose pen. Patient communities called this the "golden dose."
What this requires
- Insulin syringes with an appropriate gauge needle (typically 29–31G, 4–8mm length)
- Correct technique for drawing medication from the pen into the syringe
- Understanding of subcutaneous injection technique — the same sites and approach as the auto-injector
- Awareness that the residual volume varies between pens and should not be assumed to be a precise dose
The golden dose requires correct syringe technique. Incorrect needle gauge, contamination of the remaining pen contents, air bubbles, or incorrect injection technique all carry risks that don't exist with the auto-injector. This is not something to attempt without specific guidance. If your prescriber is familiar with this approach, ask them to demonstrate the syringe technique. If they're not, the click dosing strategy achieves similar cost savings with less complexity.
Strategy 4: Extended interval dosing
Mounjaro and Wegovy are prescribed as once-weekly injections. But tirzepatide (Mounjaro's active compound) has a half-life of approximately five days — meaning blood levels don't drop to zero between weekly injections. They decline but remain meaningfully above zero at day seven.
Some people find that extending to fortnightly injections — once every two weeks rather than every week — maintains sufficient appetite suppression for their needs, particularly during a weight maintenance phase rather than active weight loss.
What the evidence says
There are no clinical trials specifically studying fortnightly Mounjaro for weight maintenance. This is extrapolated from pharmacokinetic data and patient experience in online communities. What we can say with confidence:
- Blood levels at day 14 will be substantially lower than at day 7 — the medication is still present but at reduced concentration
- Appetite suppression will likely be reduced compared to weekly dosing, particularly in days 10–14
- For active weight loss, the evidence clearly supports weekly dosing — this strategy is more plausible for maintenance
- Individual pharmacokinetics vary — some people will find fortnightly dosing works well; others will notice appetite returning significantly in week two
A practical approach: rather than switching to fortnightly cold, try monitoring your appetite carefully in days 8–14 of your current weekly cycle. If you consistently notice strong appetite suppression throughout the full week, fortnightly dosing is more likely to work for you. If appetite typically returns in days 5–7, fortnightly is less likely to be sufficient.
Cost planning: what each approach saves
Here's what these strategies translate to financially, using typical UK private prescription prices as of April 2026:
| Approach | Effective monthly cost | Saving vs standard | Notes |
|---|---|---|---|
| Standard 2.5mg weekly | £149–165/mo | — | Baseline. One pen per month. |
| Stay at 2.5mg (not escalating to 5mg+) | £149–165/mo | £0–600/yr vs 10mg | No cost saving at starting dose, but avoids the cost of escalation |
| Half-click dosing from 2.5mg pen | ~£75–83/mo | ~£900/yr | Each pen lasts 8 weeks. Dose effectively ~1.25mg weekly. |
| 2.5mg dose from 5mg pen (half-clicks) | ~£83–95/mo | ~£840/yr | One 5mg pen delivers 8 weeks of 2.5mg doses |
| Standard 5mg weekly | £160–180/mo | — | Next titration tier |
| 5mg dose from 10mg pen (half-clicks) | ~£100–115/mo | ~£780/yr | One 10mg pen delivers 8 weeks of 5mg doses |
| Standard 2.5mg fortnightly (maintenance) | ~£75–83/mo | ~£900/yr | One pen lasts 8 weeks. Reduced efficacy. |
| Golden dose (5 injections from 4-dose pen) | ~£120–132/mo | ~£350/yr | Requires syringe technique. Being phased out — new April 2026 pens contain less excess. Check your pen first. |
The most significant savings come from click dosing — specifically using a higher-strength pen at a lower click count. A 10mg pen used at 30 clicks per injection effectively delivers 5mg doses while costing considerably less per dose than buying 5mg pens outright. This is because higher-strength pens don't cost proportionally more — a 10mg pen at £220 used to deliver 5mg doses gives you 8 doses for £27.50 each, versus a 5mg pen at £165 giving 4 doses at £41.25 each.
Who each strategy makes most sense for
What to discuss with your prescriber
Provider prices vary significantly — and some are more flexible than others on dose customisation and pausing treatment. Compare all 42 UK providers on cleardose.
Compare providers →